Award
National Heart, Lung, and Blood Institute 5R01HL155618-05
The role of hemoglobin alpha in diabetes-related vascular dysfunction
Recipient
University of Nebraska Medical Center, Omaha, NE, United States
Award Amount
$493,082.00
Ceiling
$493,082.00
Awarded
July 18, 2025
Identifier
5R01HL155618-05
The project investigates the role of hemoglobin alpha and its glycated forms in endothelial cells in diabetes, aiming to identify novel biomarkers and therapeutic targets for vascular dysfunction in diabetic patients.
Description
This research aims to understand how modifications of hemoglobin in arteries affect vascular function in diabetes, potentially leading to new biomarkers and therapeutic targets to reduce cardiovascular risks in diabetic patients.